
Arrowhead Pharmaceuticals Inc
ARWRHealthcare|Biotechnology|USA
$59.50
-1.62 (-2.65%)
Tangible Book
$4.09
Graham Number
$11.87
About
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Stock Price
+406.8%(1Y)
Pipeline Summary
71 total trials27
Phase 1
30
Phase 2
13
Phase 3
2
Phase 4
Unknown: 2Recruiting: 14Completed: 32Active: 6Terminated: 11AVAILABLE: 1NOT_YET_RECRUITING: 2Withdrawn: 3
Active Trials (20)
Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
NCT07221344Alzheimer Disease
Phase 1Phase 2Recruiting
Enrollment: 112 participants
Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus
NCT06700538Obesity
Phase 1Phase 2Recruiting
Enrollment: 120 participants
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
NCT06822790Hypertriglyceridemia
Phase 3Recruiting
Enrollment: 869 participants
Study of ARO-CFB in Adult Healthy Volunteers
NCT06209177IgA Nephropathy
Phase 1Active
Enrollment: 49 participants
Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1
NCT06131983Facio-Scapulo-Humeral Dystrophy
Phase 1Phase 2Recruiting
Enrollment: 60 participants
BioScore
6/10
Watchlist
Ownership
Recent Insider Trades
Hamilton James CSELL
2026-03-0510,000 shares @ $64.19
Hamilton James CSELL
2026-01-0540,164 shares @ $63.11
O'Brien PatrickSELL
2026-01-0549,493 shares @ $63.11
Anzalone Christopher RichardSELL
2026-01-0213,187 shares @ $66.1
Anzalone Christopher RichardSELL
2025-12-2951,726 shares @ $69.13
Recent News
2026-03-25 18:01:08
2026-03-19 21:00:10
2026-03-02 22:00:19
2026-02-24 13:00:12
2026-02-10 12:31:35
Data last updated: Apr 7, 2026, 02:29 PM